A hybrid gene delivery platform, micro Cell Vesicle Technology (mCVT), produced from the fusion of plasma membranes and cationic lipids, is presently used to improve the transfection efficiency of hard-to-transfect (HTT) cells. The plasma membrane components of mCVTs impart specificity in cellular uptake and reduce cytotoxicity in the transfection process, while the cationic lipids complex with the genetic material and provide structural integrity to mCVTs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d0nr03784b | DOI Listing |
Publication Analysis
Top Keywords
micro cell
8
cell vesicle
8
vesicle technology
8
technology mcvt
8
gene delivery
8
hard-to-transfect htt
8
htt cells
8
cationic lipids
8
mcvt novel
4
novel hybrid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!